risperidone has been researched along with Atypical Lipomatous Tumor in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
" We have appropriated a model whereby heterochromatin is established through 24- or 48-h lipopolysaccharide (LPS) treatment, and tested the epigenetic effects of risperidone along the adenylyl cyclase/protein kinase A (AC/PKA) pathway in human liposarcoma cells that express the LPS-sensitive Toll-like receptor (TLR)-4." | 3.91 | Risperidone effects on heterochromatin: the role of kinase signaling. ( Chase, KA; Feiner, B; Melbourne, JK; Rosen, C; Sharma, RP, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feiner, B | 1 |
Chase, KA | 1 |
Melbourne, JK | 1 |
Rosen, C | 1 |
Sharma, RP | 1 |
1 other study available for risperidone and Atypical Lipomatous Tumor
Article | Year |
---|---|
Risperidone effects on heterochromatin: the role of kinase signaling.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Cell Line, Tumor; Chromosomal Proteins, Non-Histon | 2019 |